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Abstract
Background: Although the unconjugated secondary bile acids, specifically deoxycholic acid (DCA) and lithocholic
acid (LCA), are considered to be risk factors for colorectal cancer, the precise mechanism(s) by which they regulate
carcinogenesis is poorly understood. We hypothesize that the cytotoxic bile acids may promote stemness in colonic
epithelial cells leading to generation of cancer stem cells (CSCs) that play a role in the development and
progression of colon cancer.
Methods: Normal human colonic epithelial cells (HCoEpiC) were used to study bile acid DCA/LCA-mediated
induction of CSCs. The expression of CSC markers was measured by real-time qPCR. Flow cytometry was used to
isolate CSCs. T-cell factor/lymphoid-enhancing factor (TCF/LEF) luciferase assay was employed to examine the
transcriptional activity of β-catenin. Downregulation of muscarinic 3 receptor (M3R) was achieved through
transfection of corresponding siRNA.
Results: We found DCA/LCA to induce CSCs in normal human colonic epithelial cells, as evidenced by the
increased proportion of CSCs, elevated levels of several CSC markers, as well as a number of epithelial–
mesenchymal transition markers together with increased colonosphere formation, drug exclusion, ABCB1 and
ABCG2 expression, and induction of M3R, p-EGFR, matrix metallopeptidases, and c-Myc. Inhibition of M3R signaling
greatly suppressed DCA/LCA induction of the CSC marker ALDHA1 and also c-Myc mRNA expression as well as
transcriptional activation of TCF/LEF.
Conclusions: Our results suggest that bile acids, specifically DCA and LCA, induce cancer stemness in colonic
epithelial cells by modulating M3R and Wnt/β-catenin signaling and thus could be considered promoters of colon
cancer.
Keywords: Cancer stem cells, Colonospheres, ABCCB1, ABCG2, Deoxycholic acid, Lithocholic acid, Colonic epithelial
cell, matrix metallopeptidases, Wnt/β-catenin signaling
Background
Bile acids, the normal component of the luminal con-
tent, are needed for absorption of lipids, cholesterol, and
fat-soluble vitamins, and are considered to be the regula-
tors of intestinal epithelial homeostasis in the gastro-
intestinal (GI) tract [1]. It has long been known that
certain secondary bile acids, secreted into the intestinal
lumen and involved in fat absorption, can promote colon
carcinogenesis [2–4]. Levels of bile acids are known to
differ as a result of patho-physiological and environmen-
tal conditions including obesity, genetic traits, and
lifestyle [4–8].
Epidemiological studies have revealed that the inci-
dence of colorectal cancer (CRC) among populations
migrating from low-incidence to high incidence coun-
tries changes rapidly. Within one generation, the inci-
dence of CRC reached its highest level in people
migrating from Japan to Hawaii [9]. This has been
thought to be largely due to changes in diet. This infer-
ence comes from the observation that large increases in
both meat and fat-enriched diet are associated with a
rise in CRC [10]. Additionally, populations with high
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incidence of colon cancer also show an increase in fecal
concentrations of bile acids [2, 11, 12]. These observa-
tions suggest that increased exposure of the colonic
lumen to high levels of bile acids may play a role in the
natural course of development of CRC and certain bile
acids have been categorized as potential tumor-
promoting agents, particularly for colon cancer [13].
The roles of cancer stem cells (CSCs) in the mainten-
ance and progression of many types of cancer are now
well accepted and continue to gain credibility as more
evidence is uncovered. The CSC model proposes that a
population of CSCs representing a small fraction of can-
cer cells exists within the tumor. These cells are able to
self-renew and are capable of initiating carcinogenesis
and sustaining tumor growth [14]. CSCs are identified
by specific surface epitopes. In CRC, CD133, CD24,
CD44, CD166, EpCAM, and ALDHA1 are reported as
CSC markers [15–18]. Cells expressing these surface epi-
topes have the ability to form tumors at a much diluted
concentration in SCID mice that histologically resemble
the primary tumor from which they were derived [19].
Several stages of carcinogenesis in colon cancer com-
prise subpopulations of CSCs, which are responsible for
tumor cell transformation, growth, and proliferation. Re-
cently, it has been reported that the expression CSC
markers CD44 and CD166, associated with KRAS muta-
tion in primary colonic tumors, represent a higher risk
of lymph node involvement by the tumor and develop-
ment of liver and lung metastasis [18].
However, little information is available about the in-
trinsic/extrinsic factor(s) that may stimulate the gener-
ation of CSCs in the colonic mucosa. We hypothesize
that certain bile acids, specifically acid (DCA) and litho-
cholic acid (LCA), most notorious for their co-
carcinogenic activity [20–22], may induce CSCs in
colonic mucosal cells leading to the development of
CRC. Studies were conducted to test this hypothesis.
Methods
Cell culture
Normal human colonic epithelial cells (HCoEpiC) were
purchased from ScienceCell Research Laboratories
(Carlsbad, CA, USA) [23]. HCoEpiC were generated
from human colonic tissues, cryopreserved at passage
one, and delivered frozen. HCoEpiC are negative for
HIV-1, HBV, HCV, mycoplasma, bacteria, and fungi.
They can be stimulated to express HLA class II and
intercellular adhesion molecules in vivo [24]. They have
also been shown to respond to a broad array of cyto-
kines and exhibit growth characteristics [25].
All experiments were performed within 10 passages
after obtaining the cell line. The cells were maintained in
Dulbecco’s minimum essential medium (DMEM/F-12)
supplemented with 10% fetal bovine serum (Invitrogen,
Grand Island, NY, USA) and 1% gentamycin in a humidi-
fied incubator at 37 °C in an atmosphere of 95% air and
5% carbon dioxide.
mRNA quantitation
The cells, incubated with or without DCA or LCA, were
subsequently treated with TRIzol reagent (Invitrogen,
Carlsbad, CA, USA) as recommended by the manufac-
turer. RNA was isolated using the Rneasy Mini Kit
(Qiagen).
For mRNA expression, cDNA was prepared with the
SuperScript III First-Strand cDNA synthesis system for
RT-PCR (Invitrogen) and analyzed in triplicate using the
2 × SYBR Green PCR Master Mix (Applied Biosystem)
and the ABI Prism 7500 sequence detection system.
PCR consisted of denaturation at 95 °C for 10 min and
40 cycles of 95 °C for 15 sec, 60 °C for 60 sec. Real-time
qRT-PCR and analysis was performed in an Applied Bio-
systems 7500 Real Time PCR system. Ct values of
mRNAs from each sample were calculated by normaliz-
ing with internal control β-actin. Each value represents
the mean of three replicates.
The oligonucleotide primers were obtained from Inte-
grated DNA Technology Inc. (Coralville, IA, USA).
Matrix metallopeptidase (MMP) primers were the same
as those reported by Xie et al. [26]. The primers for N-
Cadherin, Slug, Twist, Vimentin, Zeb1, and Zeb2 were
reported by Farhana et al. [27] and all other gene
primers are presented in Table 1.
Fluorescence-activated cell sorting of CD44+CD166– cells
and spheroid formation
Isolation of CD44+CD166– cells
All reagents and instrumentation used for flow cytome-
try were from BD Biosciences (San Jose, CA, USA).
HCoEpiC were grown to 70–80% confluence, trypsi-
nized, and then washed with sorting buffer (1 × PBS, 5%
FCS). Cells were resuspended in 100 μl sorting buffer
and stained with fluorophore-conjugated antibodies as
follows: with anti-CD45-perCP-Cy5.5 (clone), anti-
CD44-PECy7 (clone: G44-26), and anti CD166-PE
(clone) or isotype-matched mouse IgG1-PerCP-Cy5.5,
IgG2b-PE-Cy7, and PE-mouse IgG1 K (BD Pharmingen,
San Diego, CA, USA). The stained cells were incubated
for 1 h at 4 °C, subsequently washed with PBS, and re-
suspended in 0.5 ml sorting buffer. Compo-bead plus
particles were stained in parallel, in accordance with the
manufacturer’s instructions, to provide compensation
controls. CD45+ cells were excluded from analysis as de-
scribed previously [28]. Flow cytometry was performed
on a FACS Vantage SE SORP and data were analyzed
with CellQuest.
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Formation of spheroids (colonospheres)
The sorted CD44+CD166– cells from HCoEpiC were
suspended in serum-free stem cell medium containing
DMEM/F12 (1:1) supplemented with B27 (Life Tech-
nologies, Gaithersburg, MD, USA), 20 ng/ml EGF (Bio-
mol International, Plymouth, PA, USA), 20 ng/ml
fibroblast growth factor (Biomol International), and
100 μg/ml gentamycin. Approximately 150–200 cells/
well were seeded in an ultra-low-attachment 96-well
plate (Corning Inc., Lowell, MA, USA).
After 24 h, the cells were incubated in the absence
(control) or presence of DCA or LCA for 12 days.
Spheres formed were photographed and their size was
measured utilizing an OLYMPUS CKX41 microscope
supporting an Olympus DP72 digital camera and DP2-
BSW software (Olympus Soft Imaging Solutions GmbH,
Germany).
Statistical analysis
All statistics were performed using VassarStats web stat-
istical software (Richard Lowry, Poughkeepsie, NY,
USA). One-way analysis of variance (ANOVA) was per-
formed to detect any differences between groups of con-
trol and bile acid-treated spheres. If the result of the
ANOVA is significant (P < 0.01 vs control), pairwise
comparisons between the groups were made by a post-
hoc test (Tukey’s HSD procedure). The significance
levels were set at P < 0.001, P < 0.01, and P < 0.05.
Hoechst 33342 dye exclusion assay
HCoEpiC was treated with DCA and LCA (100 μg) for
30 days. Single-cell suspensions were washed with PBS
(three times) and stained with Hoechst 33342 or H342
(5 μg/ml; Sigma Aldrich Inc., St Louis, MO, USA) for
45 min at 37 °C in Hank’s Balanced Salt Solution (HBSS)
(Invitrogen, Carlsbad), vortexing gently every 15 min.
The stained cells were collected, washed with PBS, and
resuspended in 3 ml of PBS containing 2 μg/ml of propi-
dium iodide, and subsequently analyzed under a fluores-
cent microscope under UV and bright field. The number
of viable cells that excluded dye was calculated as de-
scribed previously [29].
T-cell factor/lymphoid-enhancing factor luciferase assay
In order to determine the activation of Wnt/β-catenin
signaling, the transcription factor T-cell factor/lymph-
oid-enhancing factor (TCF/LEF)-luc reporter plasmid
(Qiagen) was used in HCoEpiC. The cells were trans-
fected with Cignal TCF/LEF-Luc reporter plasmid (SA
Biosciences, Frederick, MD, USA) using lipofectamine
3000. TCF/LEF transfected cells were treated with bile
acids for 48 h after 24 h post transfection. Cells were
harvested and analyzed for TCF/LEF activity using a lu-
ciferase assay kit (Promega-Biosciences, San Luis
Obispo, CA, USA) according to the manufacturer’s in-
struction and the activity was measured on a BioTeK
Synergy HT microplate reader.
Western blot and immunoprecipitation
For tyrosine phosphorylation studies of epidermal
growth factor receptor (EGFR), the cells were grown in
serum-free medium and treated with bile acids for 48 h,
then lysed using lysis buffer (25 mM Tris-Cl (pH 8.0),
150 mM NaCl, 0.2% nonidet P-40, 10% glycerol 10 mM
NaF, 8 mM glycerophosphate, 0.2 mM Na3VO4, 1 mM
DTT, and 10 l/ml protease inhibitor cocktail; Sigma
Aldrich).
For immunoprecipitation of protein(s), the cell lysates
containing 0.3 μg protein were incubated with 1 μg of
the anti-EGFR antibody (Santa Cruz Biotechnology) in a
total volume of 500 μl lysis buffer overnight at 4 °C.
Then 25 μl Protein G-Sepharose 4 Fast Flow beads (GE
Healthcare Biosciences, Pittsburgh, PA, USA) added to
each lysate and shaken for 2 h at 4 °C. EGFR immuno-
beads were washed with lysis buffer containing protease
inhibitors, and 20 μl loading buffer was added to each
sample before boiling for 5 min. Western blot analyses
were performed as described previously [30].
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Silencing of muscarinic 3 receptor
Human 4 unique 29mer shRNA duplexes targeting mus-
carinic 3 receptor (M3R), synthesized by Integrated Tech-
nology (IDT) using the TriFectamine kit, were utilized for
silencing M3R. The gene silencing target sequences were
from the coding sequence [PubMed:NM_000740]
(CHRM3) and siRNA sequences, 5′-GTCATCAGCTTT
GACAGATACTTTT-3′ (si-M3RT2) and 5′-GGGTCA
TTTCAATGAATCTGTTTACG-3′ (si-M3RT3). The
scrambled sequences of siRNA were used as a control.
M3R siRNA duplexes were transfected transiently in
HCoEpiC using lipofectamine 3000 (Invitrogen). Bile acid
(100 μM) was added after 24 h of post transfection and
cells were harvested 72 h post transfection for mRNA
quantitation and TCF/LEF activity.
Immunofluoresence
For β-catenin immunostaining, HCoEpiC cells were
grown on an eight-chambered slide overnight. DCA/
LCA (100 µM) were then treated with cells for 24 h and
incubated for 72 h. Cells were fixed with paraformalde-
hyde for 15 min, washed three times with PBS, and then
cells were permealized with ice-cold methanol for 5 min
and washed three times with PBS. Cells were blocked
with 5% normal goat serum in PBS at room temperature
for 1 h and then incubated with anti-β-catenin antibody
(1:100 dilution; Cell Signaling) overnight at 4 °C. After
washing with 1 × PBS, cells were incubated with anti-
rabbit IgG–FITC conjugate (1:100 dilution) antibody for
30 min at room temperature. Cells were washed with
PBS and then placed on cover slips with prolong gold
antifade reagent containing DAPI (Cell Signaling Tech-
nology, Boston, MA, USA). Cells were photographed
utilizing an Olympus microscope and an Olympus
microscope digital camera with DP2-BSW software.
Results
Bile acid induction of CSCs
The primary objective of the current investigation is to
determine whether bile acids, specifically DCA and/or
LCA, would induce CSCs in colonic epithelial cells.
In the first set of experiments, we examined the
changes in expression of several CSC markers as well as
the proportion of CSCs in HCoEpiC following exposure
to DCA or LCA for 72 h. We observed that both DCA
and LCA caused a marked 2-fold to 40-fold increase in
the mRNA levels of CSC markers CD44, CD166, and
ALDHA1 in HCoEpiC when compared with the control
(Fig. 1a–c). However, LCA was found to be more effect-
ive than DCA in inducing the expression of these
markers (Fig. 1a). In addition, the proportion of CD44-
positive and CD166-positive populations was found to
be markedly higher in DCA-treated or LCA-treated
cells, compared with the corresponding vehicle-treated
control (Fig. 1d). These observations suggest that DCA
and LCA can induce CSCs in colonic epithelial cells. To
further investigate this issue, we examined the ability of
DCA and LCA to stimulate spheroid formation by
HCoEpiC, a property common to both normal and
CSCs. To conduct this investigation, we isolated the
CD44+CD166– phenotype from HCoEpiC by flow cy-
tometry. This CSC phenotype was found to be a pre-
dictor of colonic adenoma [27, 28]. Cells were incubated
after 12 days in stem cell media in the absence or pres-
ence of DCA or LCA. Incubation in stem cell media is
known to kill epithelial cells but not stem cells/CSCs. In-
deed, after 5–6 days of incubation, some cells began to
form spheroids (surrogate tumors) in the absence or
presence of bile acids. However, at the end of the 12-day
incubation period, the size of the spheroids formed by
the CD44+CD166– CSC phenotype of HCoEpiC in the
presence of DCA or LCA was found to be markedly
greater than those formed in the absence of bile acids
(controls) (Fig. 1e). At 12 days, the DCA-treated and
LCA-treated spheroids also showed the required integ-
rity of spheroids. These observations further suggest that
bile acids induce stemness in normal human epithelial
cells.
Like normal stem cells, CSCs exhibit self-renewal in
a de-differentiated state, pluripotency, but form tu-
mors with a very small number of cells [31]. Four key
transcription factors, OCT4 (POU class 5 homeo box
1), KLF4 (Kruppel like factor 4), SOX2 (SRY-box 2),
and c-Myc (v-myc avian myelocytomatosis viral onco-
gene homolog) (OKSM), have been identified as pluri-
potency genes in CSCs. OKSM have been shown to
induce dysplasia and tumorigenesis in vivo [31–36].
In view of this, we examined the expression of KLF4,
Nanog, OCT4, and SOX2 in HCoEpiC in response to
DCA/LCA. As has been observed for CSC surface
epitopes, the expression of KLF4, Nanog, OCT4, and
SOX2 was also significantly elevated following incuba-
tion for 7 days with 100 μM DCA or LCA, when
compared with the corresponding control (Fig. 2a).
These increases were accompanied by concomitant in-
creases in the expression of N-cadherin, Slug, Twist,
Vimentin, Zeb1, and Zeb2 (Fig. 2b) which are consid-
ered to be markers of epithelial–mesenchymal transi-
tion (EMT), cells that are thought to represent CSCs
[37–39]. Taken together, the results suggest that DCA
or LCA is able to transform colonic epithelial cells
into CSCs.
To further determine whether DCA or LCA would in-
deed transform colonic epithelial cells to CSCs, the next
set of experiments was conducted. One of the primary
properties of CSCs, as opposed to adult stem cells, is
their ability to resist chemotherapy because of increased
drug efflux capacity [40]. We observed that the
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proportion of HCoEpiC that excluded Hoechst 33342
dye was greatly increased (2-fold to 3-fold) following
30 days of exposure to 100 μM of DCA or LCA, when
compared with the control (Fig. 3a). One of the reasons
for increased drug exclusion by cells is thought to be
due to the elevated levels of ABC transporter proteins
ABCB1 (ATP binding cassette subfamily B member 1)
and ABCG2 (ATP binding cassette subfamily G member
2), members of the superfamily of ATP-binding cassette
(ABC) transporters, whose primary function is to trans-
port various molecules across the intracellular and extra-
cellular membranes [40]. In HCoEpiC cells, we found
LCA treatment for 18 days to cause a significant 1.5-fold
to 2-fold increase in ABCB1 and ABCG2 mRNA levels
when compared with the control (Fig. 3b, c). A similar
phenomenon was also noted following 30-day exposure
of HCoEpiC to DCA or LCA (data not shown). These
results indicate the induction of CSCs in HCoEpiC fol-
lowing a prolonged exposure to the secondary bile acids,
DCA or LCA.
To further determine whether the presence of CSCs in
HCoEpiC would lead to the processes of carcinogenesis,
the following experiments were conducted. Earlier stud-
ies have reported that secondary bile acids such as LCA
activate M3R and that this activation is important for
colon cancer progression [41, 42]. In view of this, we ex-
amined the expression of M3R in HCoEpiC following
exposure to DCA or LCA. We found DCA or LCA to
induce an 8-fold to 12-fold increase in M3R mRNA
levels in HCoEpiC, when compared with the control
(Fig. 4a).
To further determine the role of M3R in DCA/LCA
regulation of CSCs, we downregulated the receptor in
HCoEpiC by the corresponding siRNAs. Two different
siRNAs for M3R (si-M3RT2 and si-M3RT3) were utilized.
Transfection of HCoEpiC with either si-M3RT2 or si-
M3RT3 resulted in a marked 80–85% reduction of the re-
ceptor (Fig. 4b), accompanied by a significant reduction in
the expression of ALDHA1 and c-Myc, when compared
with the corresponding control (Fig. 4c). Additionally, we
observed that while DCA caused a significant (100–300%)
increase in the expression of ALDHA1, CD166, and c-
Myc in HCoEpiC, no such increase by DCA could be ob-
served in cells when M3R was downregulated (Fig. 4d–f ).
Fig. 1 DCA and LCA induce increases in CSC markers. Quantitative real-time PCR showed significantly increased mRNA expression of CD44 (a),
CD166 (b), and ALDHA1 (c) in HCoEpiC following incubation with 100 μM DCA or LCA for 72 h. Flow cytometric analysis of HCoEpiC showing an
increased proportion of CD44-positive and CD166-positive cells following 12-day incubation in the absence (control) or presence of 100 μM DCA
or LCA (d). DCA/LCA mediated the increase in spheroid formation by the CD44+CD166– CSC phenotype of HCoEpiC (e); photomicrographs showing
spheroids formed in response to DCA or LCA at the end of the 12-day incubation period. For spheroid formation, CD44+CD166– cells were sorted by
flow cytometry and 200–300 cells were seeded with B27 containing DMEM/F12 medium in 96-well low-attachment plates; 24 h after seeding, 100 μM
DCA or LCA was added to the incubation medium, and cells were incubated for an additional 12 days. 0 Day, cell size at the time of plating. The sizes
of spheres were photographed and measured on a 100 μm scale at a magnification of 400× using an Olympus microscope. Data represent the mean
± standard deviation of 15 sphere determinations. **P < 0.01, ***P< 0.001, compared with control. Data were analyzed by ANOVA, Tukey HSD test for
multiple comparisons (e). DCA deoxycholic acid, LCA lithocholic acid
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Wnt/β-catenin signaling plays a pivotal role not only
in maintaining homeostasis of intestinal crypt but also in
regulating proliferation of colon CSCs [43–45]. We have
observed that in HCoEpiC, DCA, and LCA not only
stimulated the expression of β-catenin, but also the
Wnt/β-catenin signaling, as evidenced by the induction
of transcriptional activity of TCF/LEF (Fig. 5a, b).
The Wnt/β-catenin signaling pathway leads to de-
phosphorylation, stabilization, and nuclear transloca-
tion of β-catenin. Nuclear β-catenin forms a complex
with TCF/LEF family transcription factors and acts as
a coactivator to express target genes in canonical
Wnt signaling pathway such as CCND1 and MYC
[46, 47]. We found in HCoEpiC that exposure to
DCA/LCA resulted in a marked 2-fold to 3-fold
increase in the expression of β-catenin, accompanied
by a marked induction of transcriptional activity of
TCF/LEF, when compared with the corresponding
controls (Fig. 5a, b). We have also observed increased
nuclear localization of β-catenin in HCoEpiC follow-
ing exposure to DCA or LCA (Fig. 5c). These in-
creases were also accompanied by a 12-fold to 15-fold
increase in the level of c-Myc (Fig. 5d), one of the
downstream effectors protein of Wnt/β-catenin signal-
ing [47–49]. c-Myc also regulates stemness in CSCs
[31]. In the presence of si-M3R-RNA, DCA-mediated
stimulation of transcriptional activity of TCF/LEF was
decreased by about 45% (Fig. 5e), indicating a role for
M3R in regulating bile acid induction of carcinogen-
esis in colonic epithelial cells.
Fig. 3 DCA/LCA induction of drug exclusion in HCoEpiC. Ability of HCoEpiC cells to exclude Hoechst dye (H33342) was greatly increased
following 30-day incubation with DCA or LCA (a). Likewise, the expression of ABCB1 and ABCG2 was also increased in HCoEpiC cells following
18-day exposure to 50 μM LCA (b, c). Controls contained the appropriate vehicle. Data represent the mean ± standard deviation of three separate
determinations. **P < 0.01 and ***P <0.001 Statistical significance determined by t test. DCA (deoxycholic acid), LCA (lithocholic acid)
Fig. 2 Exposure of DCA/LCA in HCoEpiC increased the expression of pluripotency genes. Levels of mRNA encoding the pluripotency genes KLF-4,
Nanog, OCT4, and SOX2 was significantly higher in cells incubated with DCA or LCA than control cells (a). Likewise, expression of EMT regulators
N-Cadherin, Slug, Twist, Vimentin, Zeb1, and Zeb2 was also increased in response to 100 μM DCA or LCA (b). Results expressed as mean ± standard
deviation of three separate experiments. *P < 0.05, **P < 0.01 and ***P < 0.001. DCA (deoxycholic acid), LCA (lithocholic acid)
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Muscarinic agonist-induced cell proliferation is medi-
ated by cross-talk between high expression of M3R and
EGFRs in human colon cancer cells and M3R activation
causes a marked enhancement in MMPs [50, 51]. We
also found a similar phenomenon in HCoEpiC; DCA
and LCA not only produced a marked increase in the
expression of EGFR but also greatly activated EGFR, as
determined by tyrosine phosphorylation (activated form;
measured using Tyr992EGFR antibody) (Fig. 6a, b). This
increase was associated with a marked rise in MMP
mRNAs, MMP1, MMP3, and MMP10 mRNA in HCoE-
piC (Fig. 6c).
Fig. 4 DCA/LCA induction of CSC phenotypic characters in HCoEpiC is mediated by M3R and knockdown of M3R decreased ALDHA1, c-Myc, and
TCF/LCF activity in cells treated with DCA. Induction of M3R in HCoEpiC following incubation with 100 μM DCA or LCA after 72 h (a). Downregulation
of M3R in cells following transfection with either of two siRNAs (si-M3RT2 and si-M3RT3) for M3R (b). ALDHA1 and c-Myc expression is reduced in
M3R-downregulated cells (c). Suppression of DCA-induced stimulation of ALDH1, CD166, and c-Myc expression in M3R-downregulated cells (d–f). Data
represent the mean ± standard deviation of three separate determinations. *P < 0.05, **P < 0.01, and ***P < 0.001, compared with the control. DCA
(deoxycholic acid), LCA (lithocholic acid)
Fig. 5 Bile acids induce Wnt-β-catenin signaling pathways and increase the expression of the target gene c-Myc in HCoEpiC. Real-time qPCR
showing an increased expression of β-catenin mRNA in HCoEpiC cells following 72-h incubation in the presence of 100 μM DCA or LCA
(a). Induction of transcriptional activity of TCF/LEF in HCoEpiC in response to 100 μM DCA or LCA treatments for 72 h (b). Photomicrographs showing
increased nuclear localization of β-catenin in HCoEpiC following 72 h incubation with 100 μM DCA or LCA; controls were incubated with an equivalent
volume of the vehicle (c): left panel , β-catenin immunostained cells; right panel, merged photograph of β-catenin and nucleus stained with DAPI;
arrow, nuclear localization of β-catenin in cells. Increased expression of c-Myc in HCoEpiC following 72-h exposure to 100 μM DCA or LCA (d). DCA/
LCA-mediated induction of transcriptional activity of TCF/LEF is greatly suppressed in M3R-downregulated HCoEpiC (e). Cells were photographed on a
100 μm scale at a magnification of 400×. Results expressed as mean ± standard deviation of three separate experiments. *P < 0.05, **P < 0.01
and ***P< 0.001. DCA (deoxycholic acid), LCA (lithocholic acid), TCF/LEF (T-cell factor/lymphoid-enhancing factor). Diamonds represent significant reduction
in M3R down-regulated cells in response to DCA compared to those without siM3R transfected cells
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Discussion
Higher levels of secondary bile acids in feces and an in-
creased incidence of colorectal cancer (CRC) were ob-
served in patients that consumed high-fat/low-fiber diets
[52–54]. Several epidemiological studies have also re-
vealed an association between bile acids and CRC. The
presence of CRC has been associated with a higher fecal
LCA/DCA ratio and with elevated fecal secondary bile
acids levels [53–56]. Although the precise mechanism(s)
by which bile acids induce colon carcinogenesis is poorly
understood, DCA and chenodeoxycholic acid (CDCA)-
mediated genotoxicity in normal human colonic epithe-
lial cells as well as in tumor cells has been found to be
due to DNA oxidative damage [57]. Increased apoptosis
and other forms of toxicity have been observed in the
liver following prolonged exposure to high levels of bile
acids [58–61].
The hydrophobic bile acids DCA and LCA appear to
be the most significant bile acids with respect to the de-
velopment of CRC [5]. Data from several in-vitro and
in-vivo studies also support this contention. Exposure of
normal colonic epithelial cells to DCA has been shown
to cause mitotic aberrations that are precursors of aneu-
ploidy and are indicators of genome instability [6].
Our current observation that the proportion of CSCs as
well as the expression of several markers of CSCs, forma-
tion of spheroids (colonospheres), and the levels of pluri-
potency markers KLF4, Nanog, OCT4, and SOX2 and
EMT markers such as Vimentin, Slug, Twist, and Zeb2 are
greatly augmented in HCoEpiC in response to DCA or
LCA suggests that these secondary bile acids induce the
formation of CSCs. Further support for this inference
comes from the observation that drug exclusion, an inher-
ent property of CSCs as determined by exclusion of
H33342, is also markedly augmented in normal human co-
lonic epithelial cells following prolonged exposure to DCA
or LCA. The fact that the expression of multiple drug re-
sistance (MDR) transporter genes ABCB1 and ABCG2 is
also augmented by DCA and LCA provides additional
support to our contention that the secondary bile acids,
specifically DCA and LCA are able to induce transform-
ation of normal colonic epithelial cells to CSCs, which are
known to play a pivotal role in the development and pro-
gression of many malignancies, including CRC [62].
Bile acid-mediated induction of colon carcinogenesis ap-
pears to be regulated by the muscarinic cholinergic family
of G-protein-coupled receptor, which consists of five sub-
types M1R–M5R. Results from earlier studies suggest that
secondary bile acids such as LCA activate M3R and that
this activation is important for colon cancer progression
[41, 42]. In the current investigation, we have also found
M3R expression to be greatly elevated in response to bile
acids and that this increase is accompanied by a concomi-
tant rise in the expression of MMP-1, MMP3, and MMP10
mRNA in HCoEpiC. MMPs are not only important in
maintaining extracellular homeostasis but also play a
prominent role in cancer cell invasion. Overexpression of
MMP1, MMP2, MMP3, MMP7, MMP9, and MMP13 cor-
relates with worse outcomes in cancer patients [26, 63–66].
Our observation that DCA or LCA could stimulate the
expression of M3R in normal human colonic epithelial
cells and that this induction is greatly attenuated when
M3R is downregulated in colonic epithelial cells further
supports a role for M3R in regulating DCA/LCA-medi-
ated modulation of colon carcinogenesis. Additional
support for this inference comes from the observation that
DCA-mediated induction of Wnt/β-catenin signaling in
M3R-downregulated colonic epithelial cells, a prerequisite
for colon carcinogenesis [67, 68], is greatly diminished.
Conclusions
Taken together, our current data show that certain sec-
ondary bile acids, specifically DCA and LCA, which are
known for their co-carcinogenic activity, are able to in-
duce CSCs in colonic epithelial cells. This is evidenced by
the observation that DCA or LCA are not only able to
stimulate the expression of several surface epitopes of
colon CSCs but also the markers of EMT. These increases
are associated with increased spheroid formation, a rise in
the expression of multiple drug resistance transporter
genes, and drug exclusion. DCA/LCA induction of colon
carcinogenesis is found to be regulated by M3R.
Fig. 6 DCA/LCA increased the expression and activation of EGFR
in HCoEpiC. Real-time qPCR showing increased expression of
EGFR mRNA in cells in response to DCA and LCA (a). Western
blot analysis indicates increased tyrosine phosphorylation (Y992)
of EGFR in response to DCA (b). Real-time qPCR showing
changes in the expression of the MMPs in cells in response to
DCA or LCA (c). Results represent the mean of three separate
determinations ± standard deviation. ***P <0.001, compared with
control. DCA (deoxycholic acid), EGFR (epidermal growth factor
receptor), LCA (lithocholic acid), MMP (matrix metallopeptidase)
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